Public, NASDAQ:ORXE
NASDAQ Global Market
Gene Logic Renews Agreement with Agilent Technologies as Certified Service Provider
Date: Wed, 13 Aug 2008 19:36:44 GMT
Tags:
Gene Logic Renews Agreement with Agilent Technologies as Certified Service Provider
PR-CANADA.net (press release) - Aug 13, 2008
PR-CANADA.net (press release) - Aug 13, 2008
Gene Logic ( An Ocimum Biosolutions Company ) and Agilent Technologies today announced that Gene Logic has been reappointed as a Certified Microarray Service Provider for Agilent gene expression ...
Ore acquires development rights for metabolic drug from Roche
Date: Fri, 08 Aug 2008 09:52:46 GMT
Tags:
Ore acquires development rights for metabolic drug from Roche
Trading Markets (press release) - Aug 8, 2008
Trading Markets (press release) - Aug 8, 2008
Aug 08 , 2008 ( Datamonitor via COMTEX ) - - ORXED | Quote | Chart | News | PowerRating - - Ore Pharmaceuticals has acquired the exclusive development rights for the clinical - stage compound ...
Ore Pharmaceuticals Obtains Second Candidate from Roche for Repositioning
Date: Thu, 07 Aug 2008 17:17:18 GMT
Tags:
Ore Pharmaceuticals Obtains Second Candidate from Roche for Repositioning
Genetic Engineering News (press release) - Aug 7, 2008
Genetic Engineering News (press release) - Aug 7, 2008
Ore Pharmaceuticals acquired the exclusive rights for one of Roche ' s abandoned clinical - stage compounds to develop the candidate in metabolic diseases.Romazarit was being investigated by ...
Tolerx wins $15M milestone; Ore gains drug rights from Roche;
Date: Thu, 07 Aug 2008 15:49:20 GMT
Tags:
Tolerx wins $15M milestone; Ore gains drug rights from Roche;
FierceBiotech - Aug 7, 2008
FierceBiotech - Aug 7, 2008
> Tolerx has won a $15 million milestone payment from GlaxoSmithKline on its launch of a late - stage trial of an experimental diabetes therapy.Report> Ore Pharmaceuticals has acquired the exclusive ...
InvestSource, Inc.: Zynex Receives Order Increase in July
Date: Thu, 07 Aug 2008 08:44:40 GMT
Tags:
InvestSource, Inc.: Zynex Receives Order Increase in July
Trading Markets (press release) - Aug 7, 2008
Trading Markets (press release) - Aug 7, 2008
n the event of a rise in value.InvestSource , Inc . will not advise as to when it decides to sell and does not , and will not , offer any opinion as to when others should buy or sell ; each investor ...
GENE LOGIC INC Financials (EDGAR Online Financials)
Date: Wed, 13 Aug 2008 13:04:26 Etc/GMT
Tags:
GENE LOGIC INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
Date: Thu, 7 Aug 2008 21:29:14 Etc/GMT
Tags:
GENE LOGIC INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (EDGAR Online)
Date: Wed, 6 Aug 2008 21:01:01 Etc/GMT
Tags:
Ore Pharmaceuticals Acquires Rights to Develop a Second Drug Candidate from Roche (Business Wire)
Date: Wed, 6 Aug 2008 21:00:00 Etc/GMT
Tags:
GAITHERSBURG, Md.----Ore Pharmaceuticals Inc. announced today that it has acquired from Roche the exclusive development rights for the clinical-stage compound romazarit. Ore Pharmaceuticals had previously identified potentially novel therapeutic uses for romazarit in metabolic diseases and subsequently observed a lowering of lipids, weight, and glucose levels in in vivo testing.
Ore Pharmaceuticals Inc. Earnings Call scheduled for 10:00 am ET today (CCBN)
Date: Fri, 1 Aug 2008 14:00:00 Etc/GMT
Tags: